TIF is performed endoscopically using the innovative EsophyX surgical device from EndoGastric Solutions. In clinical studies, 79% of patients remained off daily PPIs (proton pump inhibitors) and 93% experienced a total elimination of heartburn at two years after the TIF procedure.
TIF was developed to emulate more invasive surgical techniques, but from within and completely without incisions and visible scars. Using the FDA-cleared EsophyX device, the procedure is performed through the mouth, rather than through an abdominal incision. Typically lasting no more than 50-60 minutes, the procedure is performed under general anesthesia and reconstructs the antireflux barrier to restore the competency of the gastroesophageal junction. Most patients can go home the next day and return to work within a few days.
The specially designed EsophyX device enters the esophagus through the mouth and is positioned at the junction of the stomach and esophagus.
The EsophyX device pulls and fastens a tissue fold.
Step 2 is repeated multiple times to reconstruct a robust, tight gastroesophageal valve (GEV) that prevents the reflux of stomach fluids up into the esophagus, resulting in the effective elimination of GERD.